drugset / Trial / NCT00534976

The Effect of Montelukast on Difficulty in Breathing After Exercise in Pediatric Patients (MK0476-377)(COMPLETED)

NCT00534976 ↗

Phase 4 Completed 364 enrolled Organon and Co
RandomizedCrossoverDouble-blindTreatment

Summary

This study will see if there is a change in breathing after exercising when the child receives study drug ( montelukast or placebo). Breathing will be measured by a spirometer before exercising and measured again several times after exercising.

Timeline

Start
2008-02
Primary completion
2010-03
Completion
2010-03

Outcome

Met primary endpoint

paper significantly attenuated after single-dose montelukast compared with placebo (15.35% versus 20.00%; p = 0.020). PMID 22221440 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 4 mg Oral
Subject Montelukast Other / unclassified 5 mg Oral